Top Markets
#1 Gravity Gravity +75.10%
#2 Galxe Galxe +57.82%
#3 TENDIES TENDIES +36.20%
#4 Railgun Railgun +36.15%
#5 Geodnet Geodnet +24.60%
#6 Fake World Assets Fake World Assets +23.71%
#7 Akedo Akedo +22.61%
#8 Injective Injective +16.93%
#9 Kinetiq Kinetiq +16.68%
#10 Collector Crypt Collector Crypt +16.50%
Coin of the day
Gravity Gravity
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Classificação em ações #36
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Preço da ação
$483.81
Valor de mercado
$379.28B
Variação (1 dia)
0.92%
Variação (1 ano)
46.65%
País
CH
Negociar Roche Holding AG (RO)

Categoria

Healthcare
Rácio P/S de Roche Holding AG (RO)
Rácio P/S em September 2026 TTM: 4.17
De acordo com os relatórios financeiros mais recentes e o preço das ações da Roche Holding AG, o rácio P/S atual (TTM) é 4.17. No final de 2026, o rácio P/S era 0.
Histórico do rácio P/S da Roche Holding AG de 2026 a 2026
Rácio P/S no final de cada ano
Ano Rácio P/S Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/S de empresas semelhantes ou concorrentes
Empresa Rácio P/S Diferença do rácio P/S País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.45 222.49%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.55 57.15%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.18 72.19%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
5.39 29.18%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
5.52 32.37%
CH